Oral nutritional supplementation is effective in the maintenance of remission in Crohn's disease

被引:109
作者
Verma, S [1 ]
Kirkwood, B [1 ]
Brown, S [1 ]
Giaffer, MH [1 ]
机构
[1] Hull Royal Infirm, Dept Gastroenterol, Hull, N Humberside, England
来源
DIGESTIVE AND LIVER DISEASE | 2000年 / 32卷 / 09期
关键词
Crohn's disease; enteral nutrition;
D O I
10.1016/S1590-8658(00)80353-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background. Enteral feeding with either elemental or polymeric diets is an established primary therapy for active Crohn's disease. However: the role of supplementing normal food with elemental diet in the long-term management of Crohn's disease has hitherto not been explored. Patients and methods. A series of 39 consecutive patients with Crohn's disease in clinical remission were studied. Of these, 21 patients (Group 1) received oral nutritional supplementation, taken in addition to their normal diet. Their outcome (relapse rate, Crohn's disease activity index, inflammatory markers) was compared with that of 18 patients (Group 2), who were maintained on a normal unrestricted diet over an observation period of 12 months. Results. A total of 17 patients (81%) tolerated the nutritional supplementation. On an intention-to-treat basis, 10 patients (48%) remained in remission for 12 months, compared to 4/18 (22%) patients in Group 2, p<0.0003. Their Crohn's disease activity index and CRP remained stable while their weight and body mass index improved during the period of nutrition therapy. Seven patients in Group 1 and 14 in Group 2 relapsed at a mean of 7.4+/-0.9 and 6.2+/-0.4 months, respectively. The response to nutrition supplement was independent of age, sex, disease duration or location. Four patients (19%) were intolerant to enteral feeding. Conclusions. Nutritional supplementation is safe, well tolerated and effective in the long-term management of patients with quiescent Crohn's disease.
引用
收藏
页码:769 / 774
页数:6
相关论文
共 23 条
[1]   CHRONIC INTERMITTENT ELEMENTAL DIET IMPROVES GROWTH FAILURE IN CHILDREN WITH CROHNS-DISEASE [J].
BELLI, DC ;
SEIDMAN, E ;
BOUTHILLIER, L ;
WEBER, AM ;
ROY, CC ;
PLETINCX, M ;
BEAULIEU, M ;
MORIN, CL .
GASTROENTEROLOGY, 1988, 94 (03) :603-610
[2]  
BEST WR, 1976, GASTROENTEROLOGY, V70, P439
[3]   Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine [J].
Bouhnik, Y ;
Lemann, M ;
Mary, JY ;
Scemama, G ;
Tai, R ;
Matuchansky, C ;
Modigliani, R ;
Rambaud, JC .
LANCET, 1996, 347 (8996) :215-219
[4]  
BOWLING TE, 1993, EUR J GASTROEN HEPAT, V5, P1
[5]   PLACEBO-CONTROLLED TRIAL OF ORAL 5-ASA IN RELAPSE PREVENTION OF CROHNS-DISEASE [J].
BRIGNOLA, C ;
IANNONE, P ;
PASQUALI, S ;
CAMPIERI, M ;
GIONCHETTI, P ;
BELLUZZI, A ;
BASSO, O ;
MIGLIOLI, M ;
BARBARA, L .
DIGESTIVE DISEASES AND SCIENCES, 1992, 37 (01) :29-32
[6]   CORTICOSTEROID OR CORTICOTROPHIN THERAPY IN CROHNS DISEASE (REGIONAL-ENTERITIS) [J].
COOKE, WT ;
FIELDING, JF .
GUT, 1970, 11 (11) :921-+
[7]   ORAL MESALAMINE (PENTASA) AS MAINTENANCE TREATMENT IN CROHNS-DISEASE - A MULTICENTER PLACEBO-CONTROLLED STUDY [J].
GENDRE, JP ;
MARY, JY ;
FLORENT, C ;
MODIGLIANI, R ;
COLOMBEL, JF ;
SOULE, JC ;
GALMICHE, JP ;
LEREBOURS, E ;
DESCOS, L ;
VITEAU, JM ;
RENE, E ;
METMAN, EH ;
BORIES, P ;
BREMONDY, A ;
BOUVRY, M ;
LAMOULIATTE, H ;
GINESTON, JL .
GASTROENTEROLOGY, 1993, 104 (02) :435-439
[8]  
GIAFFER MH, 1991, ALIMENT PHARM THERAP, V5, P115, DOI 10.1111/j.1365-2036.1991.tb00012.x
[9]   POLYMERIC ENTERAL DIETS AS PRIMARY-TREATMENT OF ACTIVE CROHNS-DISEASE - A PROSPECTIVE STEROID CONTROLLED TRIAL [J].
GONZALEZHUIX, F ;
DELEON, R ;
FERNANDEZBANARES, F ;
ESTEVE, M ;
CABRE, E ;
ACERO, D ;
ABADLACRUZ, A ;
FIGA, M ;
GUILERA, M ;
PLANAS, R ;
GASSULL, MA .
GUT, 1993, 34 (06) :778-782
[10]   INITIAL RESPONSE AND SUBSEQUENT COURSE OF CROHNS-DISEASE TREATED WITH ELEMENTAL DIET OR PREDNISOLONE [J].
GORARD, DA ;
HUNT, JB ;
PAYNEJAMES, JJ ;
PALMER, KR ;
REES, RGP ;
CLARK, ML ;
FARTHING, MJG ;
MISIEWICZ, JJ ;
SILK, DBA .
GUT, 1993, 34 (09) :1198-1202